e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Severe acute asthma and troublesome wheezing
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mepolizumab eligibility in children with severe asthma – do we need paediatric specific criteria?
B. Davies (Birmingham, United Kingdom), D. Chinthala (Birmingham, United Kingdom), S. Frost (Birmingham, United Kingdom), I. Brookes (Birmingham, United Kingdom), P. Kenia (Birmingham, United Kingdom), S. Rao (Birmingham, United Kingdom), P. Nagakumar (Birmingham, United Kingdom)
Source:
International Congress 2019 – Severe acute asthma and troublesome wheezing
Session:
Severe acute asthma and troublesome wheezing
Session type:
Thematic Poster
Number:
950
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Davies (Birmingham, United Kingdom), D. Chinthala (Birmingham, United Kingdom), S. Frost (Birmingham, United Kingdom), I. Brookes (Birmingham, United Kingdom), P. Kenia (Birmingham, United Kingdom), S. Rao (Birmingham, United Kingdom), P. Nagakumar (Birmingham, United Kingdom). Mepolizumab eligibility in children with severe asthma – do we need paediatric specific criteria?. 950
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Treatment eligibility of mepolizumab-treated severe asthma patients in clinical practice
Source: International Congress 2019 – Real-world experience of monoclonal antibodies in asthma
Year: 2019
Identifying patients with severe allergic asthma who are potentially eligible for omalizumab treatment by EU licence and NICE guidance criteria
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008
Spanish study on unmet clinical needs in patients with uncontrolled severe asthma.
Source: International Congress 2018 – Asthma management
Year: 2018
Useful malnutrition diagnostic criteria for stable COPD in Japanese patients
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
Examining the unmet need in adults with severe asthma
Source: Eur Respir Rev 2007; 16: 67-72
Year: 2007
The prevalence of severe asthma in specialist care –identifying eligible candidates for biological therapies
Source: International Congress 2017 – Clinical points to ponder in asthma
Year: 2017
Managing asthma in the outpatient clinic: Is the diagnosis of asthma confirmed objectively according to guidelines?
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Real-world patient characteristics and eligibility for biologics in severe asthma (RECOGNISE)
Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Year: 2021
The need for a specialist multidisciplinary clinic to manage paediatric patients with severe asthma in the age of biologics
Source: International Congress 2019 – PG11 Severe paediatric asthma
Year: 2019
Is mild asthma outside the guidelines?
Source: Annual Congress 2011 - Asthma: control and treatment
Year: 2011
Evaluation of a diagnostic–therapeutic pathway on GINA guidelines between specialist and primary care physicians. Study and result at 1 year in children with asthma
Source: Annual Congress 2008 - Drug therapy and assessment of control in childhood asthma
Year: 2008
Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD
Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers
Year: 2006
From guidelines to personalized treatment of children with asthma
Source: Virtual Congress 2020 – Which paediatric asthma guidelines are the most appropriate for children and adolescents?
Year: 2020
Occupational asthma audit criteria - do they meet the needs of UK specialist clinicians?
Source: International Congress 2019 – Environment, work and respiratory health in occupational and environmental lung diseases
Year: 2019
Prevalence of asthma in preschool children with different diagnostic criteria
Source: Annual Congress 2007 - Epidemiology of paediatric asthma: genes, environment and prognosis
Year: 2007
Screening for COPD and asthma in acutely admitted psychiatric patients: feasible and with a low number of patients needed to screen.
Source: International Congress 2017 – Best abstracts in physical activity and management of COPD
Year: 2017
How should asthma be diagnosed in school children? Recommendations of the evidence based ERS-Guidelines
Source: Virtual Congress 2021 – The ERS guidelines for the diagnosis of asthma in children aged 5-16 years
Year: 2021
Is there a need for pharmacoepidemiology in asthma and COPD?
Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials
Year: 2004
Defining acute asthma severity – how do worldwide asthma guidelines compare?
Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept